Chief Executive Officer Wayne Paterson outlined the company’s DurAVR transcatheter aortic valve replacement (TAVR) program ...

With transcatheter aortic valve replacement (TAVR) in its infancy in the United States, 4 major cardiology societies have released initial recommendations for creating and maintaining TAVR programs.

Six-year follow-up from a trial comparing surgery with TAVR in low-risk patients showed no difference in major events, but ...

The long-sought goal of measuring the quality of U.S. transcatheter aortic valve replacement (TAVR) programs by patient outcomes rather than by the surrogate measure of case volume is about to be ...

An Oct. 21 study in Circulation: Cardiovascular Quality and Outcomes found that most transcatheter aortic valve replacement programs are found in affluent metropolitan areas. Researchers identified ...

Cardiac rehab programs are often recommended for patients after a heart procedure. One man talks about how rehab helped him recover after a TAVR procedure.

This paper summarizes the implications of recent TAVR program expansion, supports the 2019 multisociety expert consensus recommendation of Level 1 and Level 2 valve centers, and defines the important ...

The US Centers for Medicare & Medicaid Services (CMS) has started a review of its national coverage determination (NCD) for TAVR, with the purpose of reevaluating whether procedural volume ...

Please provide your email address to receive an email when new articles are posted on . Although 583 hospitals initiated new transcatheter aortic valve replacement programs from 2012 to 2018, the bulk ...

Please provide your email address to receive an email when new articles are posted on . There are inequities in the dispersion of transcatheter aortic valve replacement, with lower rates in poorer ...

A CMS advisory panel reached no clear consensus on whether patients benefit when hospitals meet certain procedure volume thresholds for operating transcatheter aortic valve replacement (TAVR) programs ...

It would both be premature and a bit cliché to say that Edwards Lifesciences has gotten its groove back. But it would be accurate to say the transcatheter aortic valve replacement (TAVR) pioneer’s ...